Intelligent Bio Solutions (INBS) Cash & Equivalents (2020 - 2025)

Intelligent Bio Solutions' Cash & Equivalents history runs 6 years deep, the most recent figure standing at $1.0 million for Q2 2025.

• In Q2 2025, Cash & Equivalents changed N/A year-over-year to $1.0 million; the TTM figure through Jun 2025 stood at $1.0 million (changed N/A YoY), while the FY2025 annual figure was $1.0 million, changed N/A from the prior year.
• Cash & Equivalents was $1.0 million for Q2 2025 at Intelligent Bio Solutions, down from $2.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $14.3 million in Q1 2021 to a low of $1.0 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $6.6 million across 5 years, with a median of $4.9 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Cash & Equivalents surged 2842.78% in 2021, then tumbled 78.8% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $11.2 million in 2021, then tumbled by 73.98% to $2.9 million in 2022, then slumped by 61.57% to $1.1 million in 2023, then surged by 100.18% to $2.2 million in 2024, then tumbled by 54.47% to $1.0 million in 2025.
• The last three Cash & Equivalents figures came in at $1.0 million (Q2 2025), $2.8 million (Q1 2025), and $2.2 million (Q4 2024), per Business Quant data.